These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2833960)

  • 21. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro.
    Srivastava A; Bruno E; Briddell R; Cooper R; Srivastava C; van Besien K; Hoffman R
    Blood; 1990 Nov; 76(10):1997-2004. PubMed ID: 2146978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia.
    Saarinen UM; Chorba TL; Tattersall P; Young NS; Anderson LJ; Palmer E; Coccia PF
    Blood; 1986 May; 67(5):1411-7. PubMed ID: 3008891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
    Manning A; Willey SJ; Bell JE; Simmonds P
    J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literature.
    Slavov SN; Kashima S; Silva-Pinto AC; Amarilla AA; Aquino VH; Covas DT
    Braz J Infect Dis; 2013; 17(1):97-101. PubMed ID: 23290473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Congenital aplastic anemia caused by parvovirus B19 infection].
    Vepreková L; Jelínek J; Zeman J
    Cas Lek Cesk; 2001 Mar; 140(6):178-80. PubMed ID: 11347208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haematological response to parvovirus B19 infection in homozygous sickle-cell disease.
    Serjeant BE; Hambleton IR; Kerr S; Kilty CG; Serjeant GR
    Lancet; 2001 Nov; 358(9295):1779-80. PubMed ID: 11734237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation.
    Takahashi T; Ozawa K; Takahashi K; Asano S; Takaku F
    Blood; 1990 Feb; 75(3):603-10. PubMed ID: 2404522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a virus that causes transient aplastic crisis.
    Young NS; Mortimer PP; Moore JG; Humphries RK
    J Clin Invest; 1984 Jan; 73(1):224-30. PubMed ID: 6317715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dot blot hybridization assay of B19 virus DNA in clinical specimens.
    Mori J; Field AM; Clewley JP; Cohen BJ
    J Clin Microbiol; 1989 Mar; 27(3):459-64. PubMed ID: 2541166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
    Kurtzman GJ; Cohen BJ; Field AM; Oseas R; Blaese RM; Young NS
    J Clin Invest; 1989 Oct; 84(4):1114-23. PubMed ID: 2551923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematologic and hematopoietic consequences of B19 parvovirus infection.
    Young N
    Semin Hematol; 1988 Apr; 25(2):159-72. PubMed ID: 2838911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human serum parvovirus as the cause of aplastic crisis in sickle cell disease.
    Kelleher JF; Luban NL; Cohen BJ; Mortimer PP
    Am J Dis Child; 1984 Apr; 138(4):401-3. PubMed ID: 6322575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection.
    Samii K; Cassinotti P; de Freudenreich J; Gallopin Y; Le Fort D; Stalder H
    Clin Infect Dis; 1996 Jan; 22(1):162-4. PubMed ID: 8824988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human parvovirus B19 in patients with aplastic anemia.
    Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
    Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
    van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
    Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens.
    Clewley JP
    J Clin Microbiol; 1989 Dec; 27(12):2647-51. PubMed ID: 2556428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease.
    Osaki M; Matsubara K; Iwasaki T; Kurata T; Nigami H; Harigaya H; Baba K
    Ann Hematol; 1999 Feb; 78(2):83-6. PubMed ID: 10089023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parvovirus B19 infections in patients with chronic anemia.
    Heegaard ED; Myhre J; Hornsleth A; Gundestrup M; Boye H
    Haematologica; 1997; 82(4):402-5. PubMed ID: 9299850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises.
    Sant'Anna AL; Garcia Rde C; Marzoche M; da Rocha HH; Paula MT; Lobo CC; Nascimento JP
    Rev Inst Med Trop Sao Paulo; 2002; 44(4):187-90. PubMed ID: 12219109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.